Lund OsteoArthritis Division - Molecular marker research group

  • Phone+46462220762
  • Visiting addressShow on map


    221 84 Lund


Unit profile


Osteoarthritis (OA), the most common joint disease, causes pain and disability and mainly affects the knee, hip and finger joints. Treatment focuses on pain relief, physical therapy and eventually prosthesis. Cartilage proteins are degraded after joint injuries and in OA; joint trauma is a risk factor for OA, but the mechanisms leading to OA are mainly unknown. We study the molecular and structural changes that occur after knee injuries and in OA, and associate them to patient symptoms. We use cartilage explants, blood, urine and joint fluid samples from patient cohorts in order to measure protein fragments by immunological methods and mass spectrometry. Magnetic resonance imaging (MRI) is used to measure the structure and volume of joint tissues. Patient evaluation forms provide clinical data on symptoms, pain and quality of life. Molecular markers are ultimately compared with MRI and clinical data.

UKÄ subject classification

  • Orthopedics

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or